⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL872025 | 0.97 | MAPT (0.48) | — | |
| Prolonium SCHEMBL1649967 | 0.79 | MAPT (0.52) | — | |
| SCHEMBL890513 | 0.78 | — | — | |
| SCHEMBL10274560 | 0.78 | — | — | |
| Prolonium SCHEMBL5705670 | 0.76 | MAPT (0.50) | — | |
| Prolonium SCHEMBL11723705 | 0.76 | MAPT (0.50) | — | |
| Prolonium SCHEMBL2889745 | 0.76 | MAPT (0.57) | — | |
| Prolonium SCHEMBL1650849 | 0.76 | MAPT (0.50) | — | |
| Water SCHEMBL1358117 | 0.75 | MAPT (0.44) | — | |
| SCHEMBL873955 | 0.73 | MAPT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250232865-A1 | SYSTEMS AND METHODS FOR IMAGE REGISTRATION | GE Precision Healthcare LLC | 2025-07-17 | — | — | US | claimed |
| WO-2024243289-A2 | GUT MICROBE DERIVED AROMATIC AMINO ACID METABOLITES FOR DETECTION AND TREATMENT OF DISEASE | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-11-28 | — | — | WO | claimed |
| US-20240165131-A1 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | THE CLEVELAND CLINIC FOUNDATION | 2024-05-23 | — | — | US | claimed |
| US-11911399-B2 | Treating and preventing disease with TMA and TMAO lowering agents | THE CLEVELAND CLINIC FOUNDATION (US) | 2024-02-27 | — | — | US | claimed |
| US-20210186991-A1 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | THE CLEVELAND CLINIC FOUNDATION | 2021-06-24 | — | — | US | claimed |
| US-10933072-B2 | Treating and preventing disease with TMA and TMAO lowering agents | THE CLEVELAND CLINIC FOUNDATION (US) | 2021-03-02 | — | — | US | claimed |
| US-20210015439-A1 | MOLECULAR IMAGING METHOD FOR EVALUATING LIVER REGENERATION CAPACLITY AFTER ALPPS OPERATION | UNIV HARBIN MEDICAL (CN) | 2021-01-21 | — | — | US | claimed |
| US-20200197417-A1 | TREATING AND PREVENTING DISEASE WITH TMA AND TMAO LOWERING AGENTS | THE CLEVELAND CLINIC FOUNDATION | 2020-06-25 | — | — | US | claimed |
| US-20130202530-A1 | NOVEL RADIOTRACER | IMPERIAL COLLEGE (GB) | 2013-08-08 | — | — | US | claimed |
| EP-2619172-A2 | NOVEL RADIOTRACER | GE Healthcare UK Limited (GB) | 2013-07-31 | — | — | EP | claimed |
| WO-2012040138-A2 | NOVEL RADIOTRACER | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | claimed |
| US-20260008750-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE | CLEVELAND CLINIC FOUND (US) | 2026-01-08 | — | — | US | disclosed |
| US-20260001833-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE | CLEVELAND CLINIC FOUND (US) | 2026-01-01 | — | — | US | disclosed |
| US-20260000703-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR REDUCING PRODUCTION OF TRIMETHYLAMINE | CLEVELAND CLINIC FOUND (US) | 2026-01-01 | — | — | US | disclosed |
| US-12458659-B2 | Methods for treating macrophage-mediated diseases, and methods of identifying agents useful therefore | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-04 | — | — | US | disclosed |
| US-20120283490-A1 | System, Device and Method for Preparing Tracers and Transferring Materials During Radiosynthesis | SIEMENS MEDICAL SOLUTIONS USA, INC. (US) | 2012-11-08 | — | — | US | disclosed |
| EP-2511006-A2 | System, device and method for preparing tracers and transferring materials during radiosynthesis | Siemens Medical Solutions USA, Inc. (US) | 2012-10-17 | — | — | EP | disclosed |
| WO-2012040151-A2 | ISOTOPIC CARBON CHOLINE ANALOGS | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012040133-A2 | NOVEL PRECURSOR | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |
| WO-2012040138-A2 | NOVEL RADIOTRACER | GE HEALTHCARE LIMITED (GB) | 2012-03-29 | — | — | WO | disclosed |